DESULFURIZATION USING I2 AND H2O2
957
4. Novelli, A. Hydantoins of b-tetralone. Anales Farm. y Bioquim. 1954, 21, 81–84.
5. (a) McCall, J. M.; Tenbrink, R. E.; Ursprung, J. J. A new approach to triaminopyrimidine
n-oxides. J. Org. Chem. 1975, 40, 3304–3306; (b) Hu, L. Y.; Guo, J.; Magar, S.; Fischer, J.
B.; Burke-Howie, K. J.; Durant, G. J. Synthesis and pharmacological evaluation of
N-(2,5-disubstituted phenyl)-N’-(3-substituted phenyl)-N’-methylguanidines as N-methyl-
D-aspartate receptor ion-channel blockers. J. Med. Chem. 1997, 40, 4281–4289; (c)
Robinson, J. R.; Brown, W. H. Diphenylcyanamide derivatives. Can. J. Chem. 1951,
29, 1069–1074.
6. Stephens, R. W.; Domeier, L. A.; Todd, M. G.; Nelson, V. A. N-Cyanoimides: Reactivity
studies with amine nucleophiles. Tetrahedron Lett. 1992, 33, 733–736.
7. (a) Donetti, A.; Omodei-Sale, A.; Mantegani A.; Zugna, E. Secondary amines from cya-
namides: A new method for removing the cyano group. Tetrahedron Lett. 1969, 39, 3327–
3328; (b) Pala, G.; Mantegani, A.; Zugna, E. New heterocyclic systems I: 5,6-Dihydro-7H,
12H-dibenz [c,f] azocine. Tetrahedron 1970, 26, 1275–1279; (c) Currie, A. C.; Newbold,
G. T.; Spring, F. S. 14-Hydroxynorcodeine and its derivatives. J. Chem. Soc. 1961,
4693–4700.
´
8. Hulme, R.; Zamora, O. D. P.; Mota, E. J.; Pasten, M. A.; Contreras-Rojas, R.; Miranda,
R.; Valencia-Hernandez, I.; Correa-Basurto, J.; Trujillo-Ferrara, J.; Delgado, F. Cyana-
´
mide: A convenient building block to synthesize 4-aryl-2-cyanoimino-3,4-dihydro-1H-
pyrimidine systems via a multicomponent reaction. Tetrahedron 2008, 64, 3372–3380.
9. (a) Yagupolskii, L. M.; Antepohl, W.; Artunc, F.; Handrock, R.; Klebanov, B. M.;
Maletina, I. I.; Marxen, B.; Petko, K. I.; Quast, U.; Vogt, A.; Weiss, C.; Zibold, J.; Herzig,
S. Vasorelaxation by new hybrid compounds containing dihydropyridine and
pinacidil-like moieties. J. Med. Chem. 1999, 42, 5266–5271; (b) Gollasch, M.; Bychkov,
R.; Ried, C.; Behrendt, F.; Scholze, S.; Luft, F. C.; Haller, H. Pinacidil relaxes porcine
and human coronary arteries by activating ATP-dependent potassium channels in smooth
muscle cells. J. Pharmacol. Exp. Ther. 1995, 275, 681–692.
10. Kreutzberger, A.; Sellheim, M. Antimycotics XIX: 4,6-Disubstituted 2-(cyanamino)
pyrimidines. J. Heterocycl. Chem. 1985, 22, 721–723.
11. (a) Von Braun, J. Action of cyanogen bromide on tertiary amines. Ber. Dtsch. Chem. Ges.
1900, 33, 1438–1452; (b) Hu, L. Y.; Guo, J.; Magar, S. S.; Fischer, J. B.; Burke-Howie, K.
J.; Durant, G. J. Synthesis and pharmacological evaluation of N-(2,5-disubstituted
phenyl)-N’-(3-substituted phenyl)-N’-methylguanidines as N-methyl-D-aspartate receptor
ion-channel blockers. J. Med. Chem. 1997, 40, 4281–4289; (c) Kaupp, G.; Schmeyers, J.;
Boy, J. Quantitative gas–solid reactions with ClCN and BrCN: Synthesis of cyanamides,
cyanates, thiocyanates, and their derivatives. Chem. Eur. J. 1998, 4, 2467–2474.
12. Wheland, R. C.; Martin, E. L. Synthesis of substituted 7,7,8,8-tetracyanoquinodi-
methanes. J. Org. Chem. 1975, 40, 3101–3109.
13. Davis, W. A.; Cava, M. P. A new synthesis of arylmalononitriles. J. Org. Chem. 1983, 48,
2774–2775.
14. (a) Van Leusen, A. M.; Jagt, J. C. Chemistry of sulfonyl cyanides, II: Nucleophilic displa-
cements on sulfonyl cyanides. Tetrahedron Lett. 1970, 12, 967–970; (b) Hughes, T. V.;
Hammond, S. D.; Cava, M. P. A convenient new synthesis of 1-cyanobenzotriazole and
its use as a C-cyanating reagent. J. Org. Chem. 1998, 63, 401–402.
15. Wu, Y.-Q.; Limburg, D. C.; Wilkinson, D. E.; Hamilton, G. S. 1-Cyanoimidazole as a
mild and efficient electrophilic cyanating agent. Org. Lett. 2000, 2, 795–797.
16. Kim, J.-J.; Kweon, D.-H.; Cho, S.-D.; Kim, H.-K.; Jung, E.-Y.; Lee, S.-G.; Falckd, J. R.;
Yoona, Y.-J. 2-Cyanopyridazin-3(2H)-ones: Effective and chemoselective electrophilic
cyanating agents. Tetrahedron 2005, 61, 5889–5894.
17. (a) Wong, F. F.; Chen, C.-Y.; Yeh, M.-Y. Sodium bis(trimethylsilyl)amide in the
‘‘one-flask’’ transformation of isocyanates to cyanamides. Synlett. 2006, 559–562; (b)